编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
20548 | Pimicotinib | 2253123-16-7 | ≧98.0% | |
Pimicotinib是一种新型的 CSF-1R 小分子抑制剂,可口服、高选择性、 | ||||
20656 | IK-930 | 2563892-44-2 | ≧98.0% | |
IK-930 是一种新型选择性小分子 TEAD 抑制剂,可防止棕榈酸结合, | ||||
21238 | Seralutinib | 1619931-27-9 | 98% Min. | |
Seralutinib,也称为 PK-10571 和 GB002,是一种新型吸入性 Pdgfr 激酶抑 | ||||
24001 | Bomedemstat | 1990504-34-1 | ≧98.0% | |
Bomedemstat 是一种口服的、不可逆的赖氨酸特异性去甲基酶 1 (LSD1) | ||||
20471 | FHD-286 | 2671128-05-3 | ≧98.0% | |
FHD-286 is an oral, small-molecule, selective, allosteric inhibitor of BRG1 and BRM i | ||||
20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% | |
Zilurgisertib(之前称为 INCB 00928)是一种激活素受体样激酶 2(ALK2, | ||||
20549 | STC-15 | 2648257-56-9 | ≧98.0% | |
STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
23122601 | Navacaprant | 2244614-14-8 | ≧98.0% | |
Navacaprant (NMRA-335140, BTRX-140) 是一种口服、选择性、可逆的 kappa 阿 | ||||
171680 | Bexotegrast ( PLN-74809 ) | 2376257-44-0 | ≧98.0% | |
Bexotegrast(同义词:PLN-74809)是一种小分子、双重选择性 αVβ1 / α | ||||
1711225 | Fosgonimeton (ATH-1017) | 2093305-05-4 | ≧98.0% | |
Fosgonimeton (ATH-1017) 是一种小分子,旨在增强肝细胞生长因子 (HGF) | ||||
20633 | STX-478 | 2883540-92-7 | ≧98.0% | |
STX-478 is an allosteric PI3Kα inhibitor that selectively targets prevalent PI3Kα h | ||||
52013 | ONX-0914 ( PR-957 ) | 960374-59-8 | ≧95.0% | |
ONX-0914 是免疫蛋白酶体 LMP7 和 LMP2 亚基的抑制剂,在多种自身免疫 |